Showing 1–16 of 23 results
Mounjaro is a once-weekly injection that is FDA-approved to be used to decrease blood sugar (blood glucose) in adults who have type 2 diabetes. It should be used together with diet and exercise. Mounjaro has also been shown in clinical trials to be useful for weight loss. More Information: ● Mounjaro works to reduce blood…
Mounjaro is a once-weekly injection that is FDA-approved to be used to decrease blood sugar (blood glucose) in adults who have type 2 diabetes. It should be used together with diet and exercise. Mounjaro has also been shown in clinical trials to be useful for weight loss. More Information: ● Mounjaro works to reduce blood…
Mounjaro is a once-weekly injection that is FDA-approved to be used to decrease blood sugar (blood glucose) in adults who have type 2 diabetes. It should be used together with diet and exercise. Mounjaro has also been shown in clinical trials to be useful for weight loss. More Information: ● Mounjaro works to reduce blood…
Mounjaro is a once-weekly injection that is FDA-approved to be used to decrease blood sugar (blood glucose) in adults who have type 2 diabetes. It should be used together with diet and exercise. Mounjaro has also been shown in clinical trials to be useful for weight loss. More Information: ● Mounjaro works to reduce blood…
Mounjaro is a once-weekly injection that is FDA-approved to be used to decrease blood sugar (blood glucose) in adults who have type 2 diabetes. It should be used together with diet and exercise. Mounjaro has also been shown in clinical trials to be useful for weight loss. More Information: ● Mounjaro works to reduce blood…
Indications / Uses Ozempic Semaglutide 0.25mg is a prescription medication approved by the FDA used for two main uses: Type 2 diabetes: Ozempic helps manage blood sugar levels in adults with type 2 diabetes, along with diet and exercise . It works by increasing insulin production, reducing sugar production in the liver, and slowing down the…
Ozambic contains Semaglutide, which is combined with appropriate diet and exercise to control high blood sugar in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also reduce the risk of a heart attack or stroke,…
OZEMPIC is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:
Description Ozempic (semaglutide injection) 2mg/0.75 ml is a prescription medication used to treat type 2 diabetes. It belongs to a class of medications called GLP-1 receptor agonists and works by increasing the release of insulin and decreasing the release of glucagon from the pancreas. This helps to lower blood sugar levels and improve glycemic control…
Saxenda is administered as a subcutaneous injection once daily. The dose is gradually increased weekly until an optimal dose of 3.0 mg is reached to minimize side effects. The 3.0 mg is then taken until the end of treatment The recommended duration of Saxenda treatment is typically six months. However, if a patient reaches their…
Saxenda is administered as a subcutaneous injection once daily. The dose is gradually increased weekly until an optimal dose of 3.0 mg is reached to minimize side effects. The 3.0 mg is then taken until the end of treatment The recommended duration of Saxenda treatment is typically six months. However, if a patient reaches their…
Mounjaro is a report/disease administered through injection of medicine in addition to diet and exercise for better regulation of blood sugar (glucose) in adults with type 2 diabetes mellitus.
Novo Nordisk manufactures Wegovy and contains semaglutide as the active ingredient. It is used with a reduced calorie diet and an increase in physical activity for chronic weight management in: Adults with a body mass index (BMI) of greater than or equal to 30 kg/m2, or 27 kg/m2 with at least one body weight-related condition,…
Novo Nordisk manufactures Wegovy and contains semaglutide as the active ingredient. It is used with a reduced calorie diet and an increase in physical activity for chronic weight management in: Adults with a body mass index (BMI) of greater than or equal to 30 kg/m2, or 27 kg/m2 with at least one body weight-related condition,…
Novo Nordisk manufactures Wegovy which contains semaglutide as the active ingredient. It is used with a reduced calorie diet and an increase in physical activity for chronic weight management in: Adults with a body mass index (BMI) of greater than or equal to 30 kg/m2, or 27 kg/m2 with at least one body weight-related condition,…
Novo Nordisk manufactures Wegovy which contains semaglutide as the active ingredient. It is used with a reduced calorie diet and an increase in physical activity for chronic weight management in: Adults with a body mass index (BMI) of greater than or equal to 30 kg/m2, or 27 kg/m2 with at least one body weight-related condition,…
As a best medical company online, we combine purchase-ready infrastructure with deep educational guidance, enabling confident decisions for buyers, partners, investors, and producers seeking scale.
Don’t miss our future updates! Get Subscribed Today!
©2026. Berrita Pharma. All Rights Reserved.